Close
Digital Health & Ai Innovation summit 2026
LiGHT26

‘Lab on a Chip’ Allows Early Diagnosis of Disease

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Digital Manufacturing Validation Improving Device Quality

Modernizing medical device production through digital validation techniques ensures higher precision, reduces manual errors, and accelerates regulatory compliance in an increasingly complex manufacturing landscape.

Sterilization Technologies Improving Medical Device Safety

Advanced sterilization methodologies and rigorous validation protocols ensure patient safety by effectively eliminating microbial contaminants from complex medical instrumentation and single-use devices.

Cold Chain Systems Protecting Medical Product...

Maintaining the integrity of temperature-sensitive pharmaceuticals requires a robust cold chain infrastructure, combining advanced monitoring, specialized logistics, and strict regulatory adherence to ensure patient safety.
Professor Christofer Toumazou, at the Imperial College in London, has invented a‘lab on a chip’ technology that can examine a person’s DNA within about 30 minutes and diagnose certain diseases and also discover if a person has a predisposition.
This new technology termed as a major breakthrough in preventive medicine by diagnosing infectious or inherited diseases in the early stages before they’ve been identified normally. This could allow treating patients and prescribing appropriate drugs immediately.
The technology deals with pH changes as DNA strands combine together, allowing genetic sequences to be read rapidly and directly at the point of need.
Silicon transistors used in lab-on-a-chip device help identify DNA and RNA, amplifying and detecting DNA and other biomolecules using pH measurement. This is less expensive and faster than other DNA and RNA analysis methods and equipment currently available in the market.
This new microchip, which has won the European Inventor Award 2014 in the category of research, will be available in Europe within three years and later in the United States. Prototypes of the microchip should be available in early 2016.

Hospital & Healthcare Management brings together the global healthcare industry — from hospital administrators and clinical directors to health technology innovators and policy leaders — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium healthcare industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global hospital and healthcare management value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Digital Manufacturing Validation Improving Device Quality

Modernizing medical device production through digital validation techniques ensures higher precision, reduces manual errors, and accelerates regulatory compliance in an increasingly complex manufacturing landscape.

Sterilization Technologies Improving Medical Device Safety

Advanced sterilization methodologies and rigorous validation protocols ensure patient safety by effectively eliminating microbial contaminants from complex medical instrumentation and single-use devices.

Cold Chain Systems Protecting Medical Product Quality

Maintaining the integrity of temperature-sensitive pharmaceuticals requires a robust cold chain infrastructure, combining advanced monitoring, specialized logistics, and strict regulatory adherence to ensure patient safety.

Biomaterials Innovation Shaping Next Generation Devices

The rapid evolution of biocompatible materials and advanced polymers is revolutionizing the development of medical implants and wearable technologies, leading to improved patient outcomes and device longevity.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »